Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Immunol Cell Biol ; 76(5): 448-53, 1998 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9797466

RESUMO

The collaboration between T and B lymphocytes is used as an example to illustrate how the key features of immune regulation (cell interaction, reciprocal exchange of signals by cell contact, and dependence on soluble cytokines) serve as amplifying reactions. By linking cell-based amplifiers in sequence, the resulting immune response is made highly sensitive to small changes in the environment. Thus, intercellular communication in the immune system can be viewed as a higher level analogue to the kinase cascades that amplify intracellular signalling mechanisms.


Assuntos
Linfócitos B/fisiologia , Comunicação Celular/fisiologia , Cooperação Linfocítica/fisiologia , Linfócitos T/fisiologia , Animais , Formação de Anticorpos , Antígenos CD40/metabolismo , Citocinas/metabolismo , Humanos , Imunidade Celular
3.
Int Rev Immunol ; 15(1-2): 101-27, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9178074

RESUMO

Immunologists have developed a range of in vitro techniques for probing the receptor mediated response of cells comprising the immune system. An important and ubiquitous method is the use of antibodies in either soluble or aggregated form to engage cell surface receptors and transmit a signal. Models of cell and molecular interactions, derived from the use of these antibodies, form the basis of our efforts to understand and explain the corresponding in vivo systems. However, interpreting in vitro experiments and distinguishing between alternative models is difficult. This complexity is illustrated here using B cell stimulation by surface immunoglobulin and CD40. The fluorescent cell labelling dye carboxyfluorescein, diacetate, succinimidyl ester (CFSE) is used to show that many anti-Ig and CD40 stimulatory agents, used to assess the role of B cells and lymphokines, are partial agonists. By modelling each step in B cell signalling, activation and division it is possible to show that small changes in signal contributed by a second receptor can generate numerous distinct dose response curves that are highly dependent on the "efficacy" of signal transmission by the primary ligand and the number of cell divisions taken in culture. Differences in dose response curves become particularly striking if the primary activating stimulus is a partial agonist. Although exemplified here with B cell stimulation the conclusions are applicable to other in vitro activation systems and suggest ways to improve both the design and interpretation of in vitro experiments.


Assuntos
Linfócitos B/imunologia , Ativação Linfocitária , Animais , Divisão Celular , Células Cultivadas , Humanos , Switching de Imunoglobulina , Interleucina-4/farmacologia , Modelos Biológicos
4.
Arch Biochem Biophys ; 310(1): 25-31, 1994 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-8161213

RESUMO

Treatment of anti-ovalbumin rabbit IgG with diethylpyrocarbonate (DEPC) at concentrations up to 100 microM led to a progressive decrease in the rates of formation of insoluble immune complexes, without affecting the final extent of immune complex formation. DEPC concentrations approximately 10-fold higher were needed to give comparable decreases in the rates of immune complex formation by F(ab')2. Treatment of DEPC-treated IgG with hydroxylamine led to substantial restoration of the rates of formation of insoluble immune complexes. Carbethoxylation of two histidine residues per IgG molecule had little effect on rates of formation of insoluble immune complexes, but these rates were markedly decreased in samples of IgG with four to five histidines per molecule modified. There were parallel decreases in the protein A-binding activity and in the rates of formation of insoluble immune complexes in IgG treated with increasing concentrations of DEPC. The presence of complement protein C1q restored the rates of formation of insoluble immune complexes of DEPC-treated IgG.


Assuntos
Complexo Antígeno-Anticorpo/biossíntese , Dietil Pirocarbonato/farmacologia , Histidina/imunologia , Imunoglobulina G/efeitos dos fármacos , Imunoglobulina G/imunologia , Animais , Complexo Antígeno-Anticorpo/química , Complexo Antígeno-Anticorpo/efeitos dos fármacos , Complemento C1q/farmacologia , Histidina/química , Histidina/efeitos dos fármacos , Fragmentos Fab das Imunoglobulinas/química , Fragmentos Fab das Imunoglobulinas/efeitos dos fármacos , Fragmentos Fab das Imunoglobulinas/imunologia , Imunoglobulina G/química , Cinética , Testes de Precipitina , Coelhos , Proteína Estafilocócica A/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...